Annual CFI
$26.96 M
+$178.16 M+117.83%
31 December 2023
Summary:
Compass Therapeutics annual cash flow from investing activities is currently $26.96 million, with the most recent change of +$178.16 million (+117.83%) on 31 December 2023. During the last 3 years, it has risen by +$26.93 million (+70860.53%). CMPX annual CFI is now at all-time high.CMPX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$29.02 M
+$22.54 M+347.60%
01 September 2024
Summary:
Compass Therapeutics quarterly cash flow from investing activities is currently $29.02 million, with the most recent change of +$22.54 million (+347.60%) on 01 September 2024. Over the past year, it has increased by +$11.97 million (+70.20%). CMPX quarterly CFI is now at all-time high.CMPX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
$37.72 M
+$11.97 M+46.49%
01 September 2024
Summary:
Compass Therapeutics TTM cash flow from investing activities is currently $37.72 million, with the most recent change of +$11.97 million (+46.49%) on 01 September 2024. Over the past year, it has increased by +$63.71 million (+245.09%). CMPX TTM CFI is now at all-time high.CMPX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CMPX Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +117.8% | +70.2% | +245.1% |
| 3 y3 years | +10000.0% | +8006.8% | +3917.4% |
| 5 y5 years | +1434.9% | - | - |
CMPX Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +117.8% | at high | +127.5% | at high | +124.9% |
| 5 y | 5 years | at high | +117.8% | at high | +127.5% | at high | +124.9% |
| alltime | all time | at high | +117.8% | at high | +127.5% | at high | +124.9% |
Compass Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $29.02 M(+347.6%) | $37.72 M(+46.5%) |
| June 2024 | - | $6.48 M(-258.2%) | $25.75 M(+38.4%) |
| Mar 2024 | - | -$4.10 M(-164.9%) | $18.60 M(-31.0%) |
| Dec 2023 | $26.96 M(-117.8%) | $6.31 M(-63.0%) | $26.96 M(-203.7%) |
| Sept 2023 | - | $17.05 M(-2656.1%) | -$26.00 M(-37.9%) |
| June 2023 | - | -$667.00 K(-115.6%) | -$41.86 M(-71.5%) |
| Mar 2023 | - | $4.27 M(-109.2%) | -$146.74 M(-3.0%) |
| Dec 2022 | -$151.20 M(+8442.4%) | -$46.65 M(-4053.1%) | -$151.20 M(+43.5%) |
| Sept 2022 | - | $1.18 M(-101.1%) | -$105.33 M(-1.4%) |
| June 2022 | - | -$105.54 M(>+9900.0%) | -$106.88 M(+5380.9%) |
| Mar 2022 | - | -$193.00 K | -$1.95 M |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$1.77 M(-4757.9%) | - | - |
| Dec 2021 | - | -$776.00 K(+111.4%) | -$1.77 M(+79.1%) |
| Sept 2021 | - | -$367.00 K(-40.2%) | -$988.00 K(+57.3%) |
| June 2021 | - | -$614.00 K(+4623.1%) | -$628.00 K(-1797.3%) |
| Mar 2021 | - | -$13.00 K(-316.7%) | $37.00 K(-2.6%) |
| Dec 2020 | $38.00 K(-108.2%) | $6000.00(-185.7%) | $38.00 K(+18.8%) |
| Sept 2020 | - | -$7000.00(-113.7%) | $32.00 K(-17.9%) |
| June 2020 | - | $51.00 K(-525.0%) | $39.00 K(-425.0%) |
| Mar 2020 | - | -$12.00 K | -$12.00 K |
| Dec 2019 | -$466.00 K(-76.9%) | - | - |
| Dec 2018 | -$2.02 M | - | - |
FAQ
- What is Compass Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Compass Therapeutics?
- What is Compass Therapeutics annual CFI year-on-year change?
- What is Compass Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Compass Therapeutics?
- What is Compass Therapeutics quarterly CFI year-on-year change?
- What is Compass Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Compass Therapeutics?
- What is Compass Therapeutics TTM CFI year-on-year change?
What is Compass Therapeutics annual cash flow from investing activities?
The current annual CFI of CMPX is $26.96 M
What is the all time high annual CFI for Compass Therapeutics?
Compass Therapeutics all-time high annual cash flow from investing activities is $26.96 M
What is Compass Therapeutics annual CFI year-on-year change?
Over the past year, CMPX annual cash flow from investing activities has changed by +$178.16 M (+117.83%)
What is Compass Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of CMPX is $29.02 M
What is the all time high quarterly CFI for Compass Therapeutics?
Compass Therapeutics all-time high quarterly cash flow from investing activities is $29.02 M
What is Compass Therapeutics quarterly CFI year-on-year change?
Over the past year, CMPX quarterly cash flow from investing activities has changed by +$11.97 M (+70.20%)
What is Compass Therapeutics TTM cash flow from investing activities?
The current TTM CFI of CMPX is $37.72 M
What is the all time high TTM CFI for Compass Therapeutics?
Compass Therapeutics all-time high TTM cash flow from investing activities is $37.72 M
What is Compass Therapeutics TTM CFI year-on-year change?
Over the past year, CMPX TTM cash flow from investing activities has changed by +$63.71 M (+245.09%)